In tests conducted by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), a new screening technology from Smiths Detection broke new ground in efforts to find and contain COVID-19: the capability to detect the virus SARS-CoV-2 in the air. The BioFlesh Biological Identifier is a cell-based biosensor powered device paired with aerosol-collection techniques. Through their union, it’s capable of rapidly, specifically identifying biological threats such as viruses, toxins, and bacteria.

 

Read more…